top of page

INP Capital: Pioneering Biotechnology Investments!

Prospects in Biotechnology Investment

The landscape of biotechnology is rapidly evolving, attracting widespread global attention. Its interdisciplinary innovations, profound impact, and vast market potential have positioned it as a prime investment sector. Biotechnology doesn't just revolutionize medicine, health, and agriculture but also reshapes domains such as materials science and environmental conservation. With continual technological advancements and substantial capital infusion, the future of biotechnology investments appears expansive and promising.

Overview of Biotech Companies Backed by INP Capital

Recursion: Revolutionizing Drug Development in Collaboration with Nvidia

Recursion, having acquired Cyclica in 2023, stands as an advanced Canadian biotech enterprise focusing on the central nervous system, oncology, and autoimmune diseases. It champions AI-driven drug development, leveraging a distinctive proteome-wide platform. Cyclica's expanded research includes challenging targets like AlphaFold2 structures, protein-protein interactions, and oncogenic mutations, offering solutions previously deemed elusive in pharmaceutical research.

Samsara Eco: Innovating Plastic Recycling

Samsara Eco redefines our perception of end-of-life plastics, shifting away from viewing them as "waste." This groundbreaking technology not only crafts new plastics from 100% recycled materials sourced from plastic waste but also completely disengages from fossil fuels, substantially reducing the carbon footprint. Annually, this innovation could mitigate carbon dioxide emissions by a billion tons, significantly benefiting the environment.

Genecis: Converting Organic Waste into Biotech Solutions

Genecis employs cutting-edge biotechnology to convert organic waste into valuable bioplastics, epitomizing "waste regeneration." At the core lies polyhydroxyalkanoate (PHA), a naturally occurring biopolymer synthesized by various microbes. Not only does it mimic properties of traditional plastics, but crucially, it's biodegradable.

INP Capital and the Future of Biotechnology

INP Capital's biotechnology investment strategy doesn't just seek economic gains; it underscores a commitment to the future and the planet. As biotech advances and the market matures, investments in biotechnology will undeniably enhance human life and pave the way for future well-being. INP Capital eagerly anticipates co-authoring a new chapter in this field alongside its partners.


bottom of page